Skip to main content

Campral FDA Approval History

FDA Approved: Yes (Discontinued) (First approved July 29, 2004)
Brand name: Campral
Generic name: acamprosate calcium
Dosage form: Delayed-Release Tablets
Company: Allergan plc
Treatment for: Alcohol Use Disorder

Marketing Status: Discontinued

Campral (acamprosate calcium) is a synthetic compound resembling the endogenous amino acid homotaurine indicated for treating alcohol dependence.

Development timeline for Campral

Jul 29, 2004Approval Campral Forest Laboratories, Inc. and Merck - Treatment for Alcoholism

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.